New York, NY, August 15, 2014 — In a comprehensive new study published in the journal Lipids in Health and Disease (https://www.lipidworld.com/content/13/1/99) it was shown that the molecular structure and dosage of omega-3 found in oil derived from Scandinavian sources reduces the risk of heart disease more effectively than other sources.
The trial objective was to compare the increases in blood levels of omega-3 fatty acids after consumption of four different omega-3 supplements, and to assess potential changes in cardiovascular disease risk following supplementation. Results showed that oil from Scandinavia in the natural triglyceride (TG) form was 382% more effective than krill oil and 227% more effective than salmon oil. Scandinavian ethyl ester (EE) fish oil was 202% better than krill oil and 120% better than salmon oil.
With a background in fish oil dating back over 14 years, Icelandirect is a major importer and distributor of Icelandic fish oils in the U.S., including omega-3, cod liver oil and tuna oil. Icelandirect complies with US Pharmacoepeia standards to assure that its products meet the parameters defined by the Council for Responsible Nutrition and the World Health Organization. Icelandic fish oil production benefits from a protected 200-mile fishing zone in the cold, clean waters of the North Atlantic. Standards include 100% ISO 9001 and GMP-compliance, carbon-neutral production, a fully-staffed on-premises quality control lab, and products that fully conform to CA Prop 65 guidelines. Icelandirect provides oils in bulk liquid form, encapsulated, emulsified or fully packaged to the customer’s specifications for both human and pet consumption.